ABCL-509 Healthcare Utilization and Costs in Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma

Autor:	Denlinger, Nathan 1, Huang, Ying 1, Braunstein, Zachary 1, Sigmund, Audrey 1, Bajwa, Amneet 1, Kapoor, Nilesh 2, Agyeman, Akwasi 1, Fisher, Scott 1, Purdin, Zebulun 3, Neal, Alison 1, Yucebay, Filiz 1, Roddy, Julianna 1, Brammer, Jonathan 1, William, Basem 3, Saad, Ayman 1, Penza, Sam 1, Voorhees, Timothy 1, Kittai, Adam 1, de Lima, Marcos 1, Vasu, Sumithira 1, Jaglowski, Samantha 1
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S381-S382
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect